Kaplan-Meier survival analyses showed that the median survival times of lower grade glioma (LGG) patients, GBM patients, or total glioma patients with higher ISL2 expressions were all shorter than in patients with lower ISL2 expression levels (Fig. 1k-m). Here, ISL2 is linked to central nervous system cancer.